BRIEF published on 11/19/2025 at 15:50, 7 months 10 days ago Le groupe Vanguard annonce une prise de participation dans Avadel Pharmaceuticals Actionnariat Groupe Vanguard Formulaire 8.3 Avadel Pharmaceuticals Panel Irlandais Des OPA
BRIEF published on 11/19/2025 at 15:49, 7 months 10 days ago The Vanguard Group Discloses Position in Mural Oncology Form 8.3 Relevant Securities Irish Takeover Panel The Vanguard Group Mural Oncology
BRIEF published on 11/19/2025 at 15:49, 7 months 10 days ago Le groupe Vanguard dévoile sa position dans le domaine de l'oncologie murale Le Groupe Vanguard Formulaire 8.3 Oncologie Murale Titres Pertinents Panel Irlandais Des OPA
PRESS RELEASE published on 11/19/2025 at 15:48, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.67% interest in Qualcomm Incorporated. Details of securities transactions provided in Form 8.3 filing Form 8.3 Disclosure Vanguard Group Securities Transactions Qualcomm
PRESS RELEASE published on 11/19/2025 at 15:47, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as of 18 November 2025 Manufacturing Vanguard Group Financial Disclosure Stake American Axle
BRIEF published on 11/19/2025 at 15:47, 7 months 10 days ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Security Disclosure Dowlais Group
BRIEF published on 11/19/2025 at 15:47, 7 months 10 days ago Le groupe Vanguard révèle sa participation dans Dowlais Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Groupe Dowlais Déclaration De Sécurité
PRESS RELEASE published on 11/19/2025 at 15:45, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.71% stake in Avadel Pharmaceuticals plc as of 18 November 2025 Irish Takeover Panel Vanguard Group Financial Disclosure Stake Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/19/2025 at 15:44, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% stake in Mural Oncology plc as per Form 8.3 submitted on 18 November 2025 The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Stake Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/19/2025 at 15:42, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.49% interest in Dowlais Group plc's 1p ordinary securities as of 18 November 2025 The Vanguard Group Interest Disclosure 1p Ordinary Securities 5.49% Interest Dowlais Group Plc
Published on 06/30/2026 at 02:00, 5 hours 31 minutes ago MedMira Reports Third Quarter Results FY2026
Published on 06/30/2026 at 00:05, 7 hours 26 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 7 hours 45 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 9 hours 30 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/30/2026 at 07:13, 17 minutes ago L’AGF nomme M. Constant N’ZI au poste de Directeur Général du Groupe
Published on 06/30/2026 at 07:13, 17 minutes ago African Guarantee Fund appoints Mr. Constant N’ZI as Group Chief Executive Officer
Published on 06/30/2026 at 07:05, 26 minutes ago Infracore SA communique la décision de la Commission des offres publiques d'acquisition
Published on 06/30/2026 at 07:05, 26 minutes ago Infracore SA communicates the decision of the Swiss Takeover Board
Published on 06/30/2026 at 07:00, 31 minutes ago Kontron AIS Wins Major Software Contract for Rail Yard Modernization in Belgium
Published on 06/30/2026 at 07:00, 31 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
Published on 06/30/2026 at 07:00, 31 minutes ago bioMérieux dépose une demande d’autorisation à la FDA américaine pour les nouvelles versions de ses tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’améliorer la détection des agents pathogènes gastrointestinaux
Published on 06/29/2026 at 18:30, 13 hours 1 minute ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 13 hours 1 minute ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
